The Early Warning System for the Diabetic Encephalopathy

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age40-65
SponsorTang-Du Hospital

About this trial

Diabetes( mainly type II diabetes )lead to the central nervous system (CNS) function impairment, especially the mild cognitive impairment that increased the risk of progression to dementia.The primary objectives are defined according to a hierarchical design: i) to tailor and apply multi-parametric, functional MRI techniques to identify cerebral abnormalities (cerebral biomarkers) in type 2 diabetes mellitus and prodromal diabetes mellitus ; ii) to assess whether these cerebral biomarkers are associated with cognitive decrements;iii) to follow up with the putative prediabetic condition patients to verify whether they can transform into diabetes.

Eligibility criteria

Qualifiers

without dementia

Inform Consent Form

Education time more than 6 years

blood glucose matches the group standard

Disqualifiers

Pregnant woman

suffer from serious brain disease

Magnetic resonance contraindications

lack of compliance

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

300 Participants
are grouped into 3 trial groups

Sponsors and collaborators